Douglas H. Gooding
Vorstandsvorsitzender bei Altiris Therapeutics, Inc.
Profil
Douglas H.
Gooding is currently the President & Chief Executive Officer at Altiris Therapeutics, Inc. He previously worked as the Director of Business Development at Cogenics Icoria, Inc., Director at Cropsolution, Inc., and Manager of the Genomic Production Group at Incyte Pharmaceuticals, Inc. From 2001 to 2010, he served as a Venture Partner at The Aurora Funds, Inc. Mr. Gooding completed his undergraduate degree at the University of San Diego and holds an MBA from The University of North Carolina at Charlotte.
Aktive Positionen von Douglas H. Gooding
| Unternehmen | Position | Beginn |
|---|---|---|
Altiris Therapeutics, Inc.
 Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Vorstandsvorsitzender | 23.06.2009 |
Ehemalige bekannte Positionen von Douglas H. Gooding
| Unternehmen | Position | Ende |
|---|---|---|
The Aurora Funds, Inc.
 The Aurora Funds, Inc. Investment ManagersFinance The Aurora Funds Inc (Aurora Funds) is a venture capital firm founded in 1994 by Jeff Bank Clark & Scott M. Albert. The firm is headquartered in Cary, North Carolina. | Private Equity Investor | 30.04.2010 |
Incyte Pharmaceuticals, Inc.
 Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Corporate Officer/Principal | - |
Cropsolution, Inc.
 Cropsolution, Inc. Chemicals: AgriculturalProcess Industries Cropsolution, Inc. engages in the discovery and development of agrochemicals. It focuses on the discovery of molecular compounds for use as herbicides, pesticides and fungicide. The firm uses evolutionary chemistry for the discovery of novel molecular compounds that have utility as agrochemical. The company was founded in January 2001 by Eric R. Ward, Michelle D. Hunt and Scott J. Uknes and is headquartered in Cary, NC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Douglas H. Gooding
| University of San Diego | Undergraduate Degree |
| The University of North Carolina at Charlotte | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
The Aurora Funds, Inc.
The Aurora Funds, Inc. Investment ManagersFinance The Aurora Funds Inc (Aurora Funds) is a venture capital firm founded in 1994 by Jeff Bank Clark & Scott M. Albert. The firm is headquartered in Cary, North Carolina. | Finance |
Cropsolution, Inc.
Cropsolution, Inc. Chemicals: AgriculturalProcess Industries Cropsolution, Inc. engages in the discovery and development of agrochemicals. It focuses on the discovery of molecular compounds for use as herbicides, pesticides and fungicide. The firm uses evolutionary chemistry for the discovery of novel molecular compounds that have utility as agrochemical. The company was founded in January 2001 by Eric R. Ward, Michelle D. Hunt and Scott J. Uknes and is headquartered in Cary, NC. | Process Industries |
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Commercial Services |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Health Technology |
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA. | Health Technology |
